GRANT SEAN (Chief Financial Officer) received a stock award from VERA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/6/2026ACC: 0001872792-26-000002
Officer· Chief Financial Officer
Since Jul 2021
+75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
75K acquired
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
+25K
Price / share
—
Trade value
—
% of position
26.6%
2/4/2026
94.13K→119.13K
Total
Net shares
+25K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/4/2026 | A · Award | +25K | — | — | 26.6% | 94.13K | 119.13K |
| Total | +25K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Class A Common Stock
50K shares
Shares
+50K
Strike price
42.74
Held after
50K
Exercisable
—
2/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Class A Common Stock50K shares | 2/4/2026 | A · Award | +50K | 42.74 | — | 50K |
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
IndirectShares owned5K
Total
5K indirect5K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 5K | Indirect |
| Total | 5K | 5K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported